Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients

Launched by SOUTIEN AUX ACTIONS CONTRE LES MALADIES DU GLOBULE ROUGE · Dec 12, 2022

Keywords

ClinConnect Summary

This prospective, observational study will take place, as follows:

Calculation of the PRESEV score in the ER will determine or not eligibility of the patient in the DREPADOM structure. With a low score, a patient is eligible for home monitoring and after duly provided information, can sign a patient consent for the use of personal medical data.

The coordinating nurse from DREPADOM can then set up a whole network, with the delivery of oxygen supply at the patient's house, dispatch of a medical prescription to a neighboring pharmacy and daily visits from homecare service providers. Both opi...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • SS or Sβ0
• • Adult patients with a low PRESEV score
• Exclusion Criteria:
• • SC/Sβ+ patients
• • SCD adult patients with an intermediate or high PRESEV score
• • Pregnant or breastfeeding women
• • Homeless patient
• • Patients without Social Security
• • Patient deprived of liberty by judicial or administrative decision or patient under guardianship

Trial Officials